Predictive factors for treatment response and mortality in chronic pulmonary aspergillosis

Chris Kosmidis, Holly Smith, Guy Mollett, Chris Harris, Suha Akili, Rohit Bazaz

Research output: Contribution to journalArticlepeer-review


Objectives: Chronic pulmonary aspergillosis (CPA) is associated with significant mortality, and suboptimal antifungal treatment response. We describe predictive factors for treatment response and survival. Methods: We retrospectively analysed clinical, serological and radiological parameters at baseline and following antifungal treatment in patients with CPA and correlated with clinical and radiological response and survival. Results: Fifty-nine patients were included with a mean age of 61 years. Thirty (51%) had a diagnosis of COPD. On clinical assessment at 6 months, 21 (36%) had clinically improved, 20 (34%) were clinically stable and 15 (25%) had deteriorated. Radiological improvement was observed in 30 (53%), stability in 11 (19%) and deterioration in 16 (28%). Only a lower C-reactive protein (CRP) at baseline was associated with a favourable clinical-radiological response. On univariate analysis, lower CRP, higher albumin, lower Aspergillus IgG and use of inhaled steroids were associated with lower mortality. An overall favourable response at 6 months was associated with lower mortality. Conclusion: Inflammatory markers and Aspergillus IgG were predictors of mortality in CPA. This suggests that mortality in CPA is driven mainly by the chronic fungal infection itself rather than the underlying disease, therefore early optimised treatment of CPA may lead to improved outcomes.

Original languageEnglish
Pages (from-to)960-968
Number of pages9
Issue number11
Publication statusPublished - Nov 2023


  • chronic pulmonary aspergillosis
  • outcome
  • treatment


Dive into the research topics of 'Predictive factors for treatment response and mortality in chronic pulmonary aspergillosis'. Together they form a unique fingerprint.

Cite this